middle.news
Orthocell Marks Canadian Market Entry with First Remplir Sales
9:48am on Thursday 30th of April, 2026 AEST
•
Healthcare
Read Story
Orthocell Marks Canadian Market Entry with First Remplir Sales
9:48am on Thursday 30th of April, 2026 AEST
Key Points
First Remplir commercial sales in Canada post Health Canada approval
Distributor-led model enables capital-light market entry
Remplir approved and generating revenue in six countries
Strong cash position of A$48 million supports expansion
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Orthocell (ASX:OCC)
OPEN ARTICLE